

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.63296960 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.42029981 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 5.42029981 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.42029981 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.42029981 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.42029981 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.42029981 |
| 8 | response to peptidoglycan (GO:0032494) | 5.06371703 |
| 9 | cellular extravasation (GO:0045123) | 4.98837014 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.98290748 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.96930437 |
| 12 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.85567795 |
| 13 | detection of molecule of bacterial origin (GO:0032490) | 4.78450783 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 4.63132040 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.59865076 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.28496770 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.97874393 |
| 18 | germinal center formation (GO:0002467) | 3.89683657 |
| 19 | detection of other organism (GO:0098543) | 3.86894892 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.83317199 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.83317199 |
| 22 | microglial cell activation (GO:0001774) | 3.82900991 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.80241751 |
| 24 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.79958716 |
| 25 | response to host immune response (GO:0052572) | 3.79958716 |
| 26 | response to muramyl dipeptide (GO:0032495) | 3.79086650 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 3.78812440 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.71696936 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.71011655 |
| 30 | T cell migration (GO:0072678) | 3.70573189 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.69802331 |
| 32 | macrophage activation (GO:0042116) | 3.69450898 |
| 33 | detection of external biotic stimulus (GO:0098581) | 3.68338090 |
| 34 | negative regulation of T cell mediated immunity (GO:0002710) | 3.64844687 |
| 35 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.60616067 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.59103832 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.55724195 |
| 38 | positive regulation of granulocyte differentiation (GO:0030854) | 3.55123558 |
| 39 | neutrophil activation (GO:0042119) | 3.54317525 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.50395992 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.47636160 |
| 42 | response to host (GO:0075136) | 3.47636160 |
| 43 | response to host defenses (GO:0052200) | 3.47636160 |
| 44 | neutrophil mediated immunity (GO:0002446) | 3.41525875 |
| 45 | defense response to protozoan (GO:0042832) | 3.39501727 |
| 46 | detection of bacterium (GO:0016045) | 3.38728235 |
| 47 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.37316567 |
| 48 | detection of biotic stimulus (GO:0009595) | 3.36207891 |
| 49 | granulocyte activation (GO:0036230) | 3.36191358 |
| 50 | erythrocyte development (GO:0048821) | 3.35047445 |
| 51 | regulation of hypersensitivity (GO:0002883) | 3.32368124 |
| 52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.32212868 |
| 53 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.31170485 |
| 54 | positive regulation of mast cell activation (GO:0033005) | 3.31047227 |
| 55 | negative thymic T cell selection (GO:0045060) | 3.29411089 |
| 56 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.28691647 |
| 57 | response to protozoan (GO:0001562) | 3.24074449 |
| 58 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.23963380 |
| 59 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.21728407 |
| 60 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.18579924 |
| 61 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.18030261 |
| 62 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.15612413 |
| 63 | positive regulation of mast cell degranulation (GO:0043306) | 3.15612413 |
| 64 | regulation of mast cell activation (GO:0033003) | 3.12648130 |
| 65 | regulation of interferon-alpha production (GO:0032647) | 3.12327661 |
| 66 | B cell receptor signaling pathway (GO:0050853) | 3.12291203 |
| 67 | leukocyte aggregation (GO:0070486) | 3.11764133 |
| 68 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.11283579 |
| 69 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.10450925 |
| 70 | negative T cell selection (GO:0043383) | 3.09143243 |
| 71 | positive regulation of interferon-alpha production (GO:0032727) | 3.09127264 |
| 72 | type I interferon signaling pathway (GO:0060337) | 3.05469998 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.05469998 |
| 74 | T-helper 1 type immune response (GO:0042088) | 3.05379201 |
| 75 | myeloid leukocyte mediated immunity (GO:0002444) | 3.05160918 |
| 76 | response to type I interferon (GO:0034340) | 3.04787097 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03994148 |
| 78 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00690026 |
| 79 | regulation of B cell differentiation (GO:0045577) | 3.00451614 |
| 80 | positive thymic T cell selection (GO:0045059) | 2.98905260 |
| 81 | regulation of antigen processing and presentation (GO:0002577) | 2.96869438 |
| 82 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.94705774 |
| 83 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.94501080 |
| 84 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.90087546 |
| 85 | positive regulation of type 2 immune response (GO:0002830) | 2.89981631 |
| 86 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.88919741 |
| 87 | regulation of B cell apoptotic process (GO:0002902) | 2.88427399 |
| 88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.88392403 |
| 89 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87233847 |
| 90 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.85570961 |
| 91 | regulation of leukocyte degranulation (GO:0043300) | 2.85183814 |
| 92 | hepatocyte apoptotic process (GO:0097284) | 2.84814710 |
| 93 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80564681 |
| 94 | respiratory burst (GO:0045730) | 2.78585754 |
| 95 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.78473695 |
| 96 | B cell mediated immunity (GO:0019724) | 2.78072754 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.76450774 |
| 98 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.76450774 |
| 99 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.75975907 |
| 100 | positive regulation of interferon-beta production (GO:0032728) | 2.73779036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.01879697 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.92339062 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.81866495 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.66492932 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.61570023 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.55203599 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.35614720 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.26370802 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.12264438 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.02789717 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.95625952 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.86884344 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.84040727 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.80578560 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75615641 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.67048488 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.60518052 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52914427 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.42370132 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.42019444 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.39506538 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.37221481 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.32229230 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.31481682 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.31459770 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.30258979 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.28441585 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25201119 |
| 29 | GATA1_19941826_ChIP-Seq_K562_Human | 2.17875276 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 2.13493469 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.12491803 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.04037818 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.03617098 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.02481776 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02143684 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.97670147 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.96970874 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.94840629 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.92527190 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92357050 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84933993 |
| 42 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.84209600 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.83705368 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77943414 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.71439283 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.67243935 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.64467835 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63717981 |
| 49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.61736473 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.59250484 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57582096 |
| 52 | GATA2_19941826_ChIP-Seq_K562_Human | 1.54301115 |
| 53 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.53034967 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51822720 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.48979557 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48651286 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.44245421 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39254773 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39253395 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35877100 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34890778 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33270705 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32285895 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31250531 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30619312 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30550664 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28255268 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26258925 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25847410 |
| 70 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.25611219 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23978631 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23220493 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22419181 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21733778 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21381294 |
| 76 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20554109 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19827778 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19417551 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15258946 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14874719 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14555514 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12921105 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12381938 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09955288 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09233088 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07100609 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04454715 |
| 88 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03738847 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02734221 |
| 90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92138991 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89804827 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.89143705 |
| 93 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87741349 |
| 94 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85912202 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82828496 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79868959 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78517418 |
| 98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.72874438 |
| 99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.72573683 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72500739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.30899285 |
| 2 | MP0003436_decreased_susceptibility_to | 3.92188400 |
| 3 | MP0003724_increased_susceptibility_to | 3.78303897 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.73907495 |
| 5 | MP0001545_abnormal_hematopoietic_system | 3.35141701 |
| 6 | MP0005397_hematopoietic_system_phenotyp | 3.35141701 |
| 7 | MP0000569_abnormal_digit_pigmentation | 3.14288310 |
| 8 | MP0003656_abnormal_erythrocyte_physiolo | 2.79539335 |
| 9 | MP0001800_abnormal_humoral_immune | 2.65852132 |
| 10 | MP0002419_abnormal_innate_immunity | 2.62610531 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.57526575 |
| 12 | MP0006082_CNS_inflammation | 2.53351318 |
| 13 | MP0005025_abnormal_response_to | 2.49502151 |
| 14 | MP0000685_abnormal_immune_system | 2.46776392 |
| 15 | MP0009785_altered_susceptibility_to | 2.44993398 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.38503366 |
| 17 | MP0009278_abnormal_bone_marrow | 2.36903128 |
| 18 | MP0005671_abnormal_response_to | 2.36571139 |
| 19 | MP0002723_abnormal_immune_serum | 2.32557103 |
| 20 | MP0005387_immune_system_phenotype | 2.29496073 |
| 21 | MP0001790_abnormal_immune_system | 2.29496073 |
| 22 | MP0002132_abnormal_respiratory_system | 2.29169441 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.25937532 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.20920900 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.18890276 |
| 26 | MP0008260_abnormal_autophagy | 2.17578574 |
| 27 | MP0002420_abnormal_adaptive_immunity | 2.12660649 |
| 28 | MP0001819_abnormal_immune_cell | 2.11128846 |
| 29 | MP0003300_gastrointestinal_ulcer | 2.05434594 |
| 30 | MP0004947_skin_inflammation | 1.89755790 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.87916757 |
| 32 | MP0002398_abnormal_bone_marrow | 1.81090133 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.80970650 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.78383082 |
| 35 | MP0005451_abnormal_body_composition | 1.77580072 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.75902569 |
| 37 | MP0002405_respiratory_system_inflammati | 1.71497971 |
| 38 | MP0009764_decreased_sensitivity_to | 1.71448533 |
| 39 | MP0002332_abnormal_exercise_endurance | 1.68651152 |
| 40 | MP0001853_heart_inflammation | 1.67406188 |
| 41 | MP0000716_abnormal_immune_system | 1.67386858 |
| 42 | MP0000015_abnormal_ear_pigmentation | 1.64070450 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.55851284 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.50998096 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.49289304 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.45879099 |
| 47 | MP0002722_abnormal_immune_system | 1.45568500 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.42867689 |
| 49 | MP0002429_abnormal_blood_cell | 1.40516314 |
| 50 | MP0008004_abnormal_stomach_pH | 1.38612718 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.36846177 |
| 52 | MP0008469_abnormal_protein_level | 1.33246252 |
| 53 | MP0003828_pulmonary_edema | 1.30206704 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.28124531 |
| 55 | MP0002006_tumorigenesis | 1.26496517 |
| 56 | MP0001873_stomach_inflammation | 1.23902388 |
| 57 | MP0002009_preneoplasia | 1.21053901 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.20831956 |
| 59 | MP0003075_altered_response_to | 1.20096264 |
| 60 | MP0003045_fibrosis | 1.15804133 |
| 61 | MP0004883_abnormal_blood_vessel | 1.14470802 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.13686954 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.09567064 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.09304442 |
| 65 | MP0005310_abnormal_salivary_gland | 1.07788049 |
| 66 | MP0009763_increased_sensitivity_to | 1.04884772 |
| 67 | MP0004510_myositis | 1.04648797 |
| 68 | MP0009765_abnormal_xenobiotic_induced | 1.03180353 |
| 69 | MP0003690_abnormal_glial_cell | 1.00963158 |
| 70 | MP0005083_abnormal_biliary_tract | 1.00185737 |
| 71 | MP0005164_abnormal_response_to | 0.96058118 |
| 72 | MP0000858_altered_metastatic_potential | 0.95010935 |
| 73 | MP0001851_eye_inflammation | 0.90932329 |
| 74 | MP0004381_abnormal_hair_follicle | 0.89095749 |
| 75 | MP0005076_abnormal_cell_differentiation | 0.88991510 |
| 76 | MP0005075_abnormal_melanosome_morpholog | 0.87371691 |
| 77 | MP0000343_altered_response_to | 0.84916161 |
| 78 | MP0005166_decreased_susceptibility_to | 0.83833091 |
| 79 | MP0003448_altered_tumor_morphology | 0.79326835 |
| 80 | MP0003091_abnormal_cell_migration | 0.77878302 |
| 81 | MP0003866_abnormal_defecation | 0.76543886 |
| 82 | MP0001663_abnormal_digestive_system | 0.74988514 |
| 83 | MP0005666_abnormal_adipose_tissue | 0.71240675 |
| 84 | MP0000371_diluted_coat_color | 0.70283456 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.67359319 |
| 86 | MP0005390_skeleton_phenotype | 0.67316808 |
| 87 | MP0000249_abnormal_blood_vessel | 0.65190304 |
| 88 | MP0005376_homeostasis/metabolism_phenot | 0.62220308 |
| 89 | MP0009115_abnormal_fat_cell | 0.62017265 |
| 90 | MP0000604_amyloidosis | 0.61108818 |
| 91 | MP0002019_abnormal_tumor_incidence | 0.60816803 |
| 92 | MP0004130_abnormal_muscle_cell | 0.60558939 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.59526693 |
| 94 | MP0003795_abnormal_bone_structure | 0.59214835 |
| 95 | MP0005266_abnormal_metabolism | 0.58166407 |
| 96 | MP0008874_decreased_physiological_sensi | 0.58097140 |
| 97 | MP0002933_joint_inflammation | 0.54903866 |
| 98 | MP0009840_abnormal_foam_cell | 0.54821338 |
| 99 | MP0000609_abnormal_liver_physiology | 0.54601453 |
| 100 | MP0005334_abnormal_fat_pad | 0.53814645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.51441126 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 5.01174369 |
| 3 | Optic neuritis (HP:0100653) | 5.01174369 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.00740141 |
| 5 | Myositis (HP:0100614) | 4.83553399 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.80415528 |
| 7 | Orchitis (HP:0100796) | 4.80176393 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.27883689 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.14757869 |
| 10 | Petechiae (HP:0000967) | 4.00421656 |
| 11 | Prolonged bleeding time (HP:0003010) | 3.97244232 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.95693967 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.87131496 |
| 14 | Stomatitis (HP:0010280) | 3.81602689 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 3.72011301 |
| 16 | Recurrent viral infections (HP:0004429) | 3.71534989 |
| 17 | Recurrent skin infections (HP:0001581) | 3.66421723 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 3.64553635 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.64335729 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.64335729 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.47035806 |
| 22 | Increased serum ferritin (HP:0003281) | 3.45967667 |
| 23 | Epistaxis (HP:0000421) | 3.43688276 |
| 24 | Encephalitis (HP:0002383) | 3.36774115 |
| 25 | Keratoconjunctivitis (HP:0001096) | 3.31244688 |
| 26 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.28727053 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.28716977 |
| 28 | Arterial thrombosis (HP:0004420) | 3.26225520 |
| 29 | Meningitis (HP:0001287) | 3.24143629 |
| 30 | T lymphocytopenia (HP:0005403) | 3.22492376 |
| 31 | Gingival bleeding (HP:0000225) | 3.11050008 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 3.08865696 |
| 33 | Impaired platelet aggregation (HP:0003540) | 3.08616889 |
| 34 | Abnormal platelet function (HP:0011869) | 3.08616889 |
| 35 | Abnormality of T cell number (HP:0011839) | 3.08385332 |
| 36 | Gingivitis (HP:0000230) | 3.01114251 |
| 37 | Hemoptysis (HP:0002105) | 2.99786715 |
| 38 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.95187720 |
| 39 | Vasculitis (HP:0002633) | 2.92987789 |
| 40 | Pulmonary infiltrates (HP:0002113) | 2.87385372 |
| 41 | Leukocytosis (HP:0001974) | 2.84242195 |
| 42 | Colitis (HP:0002583) | 2.79585353 |
| 43 | Polycythemia (HP:0001901) | 2.76524895 |
| 44 | Chest pain (HP:0100749) | 2.76384465 |
| 45 | Abnormality of iron homeostasis (HP:0011031) | 2.76081890 |
| 46 | Abnormality of the fingertips (HP:0001211) | 2.75827456 |
| 47 | Amyloidosis (HP:0011034) | 2.75689723 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 2.74330531 |
| 49 | Obstructive lung disease (HP:0006536) | 2.68739465 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.68739465 |
| 51 | Abnormality of T cells (HP:0002843) | 2.63605639 |
| 52 | Loss of speech (HP:0002371) | 2.62478579 |
| 53 | Increased IgM level (HP:0003496) | 2.60852837 |
| 54 | Granulocytopenia (HP:0001913) | 2.60200912 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.59237753 |
| 56 | Urticaria (HP:0001025) | 2.58433127 |
| 57 | Cellulitis (HP:0100658) | 2.52422435 |
| 58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.48173192 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.48173192 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.48173192 |
| 61 | Increased IgE level (HP:0003212) | 2.46548220 |
| 62 | Episodic fever (HP:0001954) | 2.46362473 |
| 63 | Vertigo (HP:0002321) | 2.42921440 |
| 64 | Alveolar cell carcinoma (HP:0006519) | 2.41786809 |
| 65 | Pustule (HP:0200039) | 2.40989525 |
| 66 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.39685352 |
| 67 | Anorexia (HP:0002039) | 2.39555206 |
| 68 | Abnormality of the pleura (HP:0002103) | 2.36192421 |
| 69 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.35608852 |
| 70 | Dry hair (HP:0011359) | 2.34958207 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.34749506 |
| 72 | Gangrene (HP:0100758) | 2.34535390 |
| 73 | Agammaglobulinemia (HP:0004432) | 2.29702449 |
| 74 | Neurodegeneration (HP:0002180) | 2.29151051 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 2.25725782 |
| 76 | Osteomyelitis (HP:0002754) | 2.25627101 |
| 77 | Spontaneous hematomas (HP:0007420) | 2.23021175 |
| 78 | Acanthocytosis (HP:0001927) | 2.20994745 |
| 79 | Reticulocytosis (HP:0001923) | 2.18137256 |
| 80 | Peritonitis (HP:0002586) | 2.17313309 |
| 81 | Polyneuropathy (HP:0001271) | 2.16770182 |
| 82 | Viral hepatitis (HP:0006562) | 2.16241545 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.15553784 |
| 84 | Amaurosis fugax (HP:0100576) | 2.15082496 |
| 85 | Anhidrosis (HP:0000970) | 2.14933422 |
| 86 | Eosinophilia (HP:0001880) | 2.13824297 |
| 87 | Poikilocytosis (HP:0004447) | 2.12068920 |
| 88 | Albinism (HP:0001022) | 2.12050465 |
| 89 | Fatigue (HP:0012378) | 2.09456905 |
| 90 | Abnormality of the peritoneum (HP:0002585) | 2.09123123 |
| 91 | Acute hepatic failure (HP:0006554) | 2.03675281 |
| 92 | Hematochezia (HP:0002573) | 2.02510924 |
| 93 | Pulmonary embolism (HP:0002204) | 2.02102715 |
| 94 | Chronic otitis media (HP:0000389) | 1.97493234 |
| 95 | Joint swelling (HP:0001386) | 1.96888830 |
| 96 | Abnormality of the endocardium (HP:0004306) | 1.95588918 |
| 97 | Glomerulopathy (HP:0100820) | 1.94888718 |
| 98 | Increased cerebral lipofuscin (HP:0011813) | 1.94566039 |
| 99 | Global brain atrophy (HP:0002283) | 1.93191398 |
| 100 | Keratitis (HP:0000491) | 1.91068238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.59169002 |
| 2 | RIPK4 | 3.58797880 |
| 3 | MAP4K1 | 2.98826541 |
| 4 | PRPF4B | 2.97052578 |
| 5 | TYK2 | 2.66543992 |
| 6 | MAP2K3 | 2.64505182 |
| 7 | TXK | 2.40869999 |
| 8 | IKBKE | 2.33785896 |
| 9 | BMPR2 | 2.00792673 |
| 10 | IRAK4 | 1.97220365 |
| 11 | ZAP70 | 1.96719794 |
| 12 | JAK1 | 1.91224781 |
| 13 | PIK3CG | 1.84416695 |
| 14 | ERN1 | 1.81447402 |
| 15 | MAP3K13 | 1.81372128 |
| 16 | JAK3 | 1.79493656 |
| 17 | CSK | 1.78098769 |
| 18 | MAP3K14 | 1.74724062 |
| 19 | PIM2 | 1.74198609 |
| 20 | IKBKB | 1.69207750 |
| 21 | BTK | 1.68691815 |
| 22 | SYK | 1.67858900 |
| 23 | FES | 1.67847310 |
| 24 | JAK2 | 1.66625497 |
| 25 | TAOK2 | 1.55320452 |
| 26 | RAF1 | 1.53428373 |
| 27 | TBK1 | 1.49618781 |
| 28 | GRK6 | 1.48795940 |
| 29 | MAP3K3 | 1.36446034 |
| 30 | SCYL2 | 1.36189554 |
| 31 | KIT | 1.34840108 |
| 32 | IRAK3 | 1.32183368 |
| 33 | TAOK3 | 1.30677558 |
| 34 | HCK | 1.28170468 |
| 35 | LYN | 1.22796803 |
| 36 | TEC | 1.17786179 |
| 37 | TESK2 | 1.16233585 |
| 38 | MAP3K1 | 1.14235606 |
| 39 | PIM1 | 1.13960387 |
| 40 | MATK | 1.12810890 |
| 41 | ITK | 1.11431648 |
| 42 | IRAK1 | 1.11184627 |
| 43 | FGR | 1.10376306 |
| 44 | TAOK1 | 1.09838304 |
| 45 | LCK | 1.08242514 |
| 46 | MAP3K11 | 1.07809065 |
| 47 | MAP3K6 | 1.07705866 |
| 48 | GRK7 | 1.00939262 |
| 49 | NME2 | 0.97611816 |
| 50 | PKN1 | 0.96682658 |
| 51 | IRAK2 | 0.93399825 |
| 52 | TNK2 | 0.91052396 |
| 53 | CDK19 | 0.90868942 |
| 54 | MARK2 | 0.88999036 |
| 55 | MARK3 | 0.88284587 |
| 56 | RIPK1 | 0.85729153 |
| 57 | TGFBR2 | 0.84043195 |
| 58 | CSF1R | 0.83642171 |
| 59 | EPHB1 | 0.77774866 |
| 60 | CHUK | 0.77530432 |
| 61 | MOS | 0.77494279 |
| 62 | KSR2 | 0.74882033 |
| 63 | CDK12 | 0.73981683 |
| 64 | MAPK7 | 0.73780003 |
| 65 | MAPK11 | 0.73623608 |
| 66 | SGK2 | 0.72501812 |
| 67 | AKT3 | 0.71058639 |
| 68 | BRD4 | 0.70355074 |
| 69 | STK10 | 0.67796807 |
| 70 | PDK1 | 0.67106160 |
| 71 | SGK3 | 0.62492543 |
| 72 | KDR | 0.61710833 |
| 73 | CDC42BPA | 0.60756879 |
| 74 | MAP3K5 | 0.59143131 |
| 75 | FGFR3 | 0.58585299 |
| 76 | CLK1 | 0.55323532 |
| 77 | EPHA3 | 0.54843974 |
| 78 | ERBB2 | 0.54506446 |
| 79 | PDPK1 | 0.53134407 |
| 80 | MAPK12 | 0.52487255 |
| 81 | RPS6KL1 | 0.52481871 |
| 82 | RPS6KC1 | 0.52481871 |
| 83 | STK4 | 0.50888254 |
| 84 | TRIB3 | 0.50603765 |
| 85 | MAP3K7 | 0.50368626 |
| 86 | STK16 | 0.50194078 |
| 87 | CDK4 | 0.49781980 |
| 88 | RPS6KA6 | 0.46994911 |
| 89 | FGFR4 | 0.46862714 |
| 90 | PRKD1 | 0.45539752 |
| 91 | MAPK3 | 0.45186688 |
| 92 | TRPM7 | 0.44651127 |
| 93 | YES1 | 0.44332602 |
| 94 | WNK1 | 0.44113994 |
| 95 | PRKD2 | 0.42313322 |
| 96 | TTN | 0.39973811 |
| 97 | RET | 0.37977027 |
| 98 | CAMK1D | 0.37951135 |
| 99 | KSR1 | 0.35768456 |
| 100 | ABL1 | 0.33349361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.17171420 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.76079251 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.51247402 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.49641326 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.33832787 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.28997363 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28496884 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.22979498 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.16816590 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.16122389 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.14906475 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.14019643 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11271032 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.08255189 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01081966 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.90875190 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.86346252 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.81232087 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.78385734 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.77482347 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.74655194 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.73577347 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.72701675 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.68497488 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.64016583 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.59945090 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59916559 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56581702 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.56312886 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52726512 |
| 31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46249920 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45073416 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42648572 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.42306142 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40186574 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.40108421 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.39911015 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37672808 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.36157472 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.31646641 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.31057346 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24952535 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22933150 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.15214895 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.14556462 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13523348 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09057924 |
| 48 | Bladder cancer_Homo sapiens_hsa05219 | 1.02039240 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01205456 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.96841638 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96406588 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91890504 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 0.91242940 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90973311 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 0.88639437 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88293312 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87577580 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84264165 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.83603582 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81313176 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77039398 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76879740 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 0.75049099 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74812176 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73347289 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70483156 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70258271 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69445256 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69311752 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67971111 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67329939 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64050011 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62971791 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59689215 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58188479 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.54612145 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52951506 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52794713 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52531368 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52434764 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52276463 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52036757 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47894036 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47776225 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46673322 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46438674 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45928207 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.43990389 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42687309 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39615824 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38163420 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37508522 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37165906 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36275289 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36150779 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.35015554 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34990842 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34473217 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32115347 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.30293350 |

